Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 40

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 40
---
-Funded Warrants issued in this offering, if any, and no exercise of the Warrants being issued in this offering).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

| Use of Proceeds |     | We currently intend to use the net proceeds to us from this offering for working capital and general corporate purposes. See the section of this prospectus titled “Use of Proceeds” beginning on page 25. |

<div align='center'>17</div>

| Listing |     | Our common stock trades on The Nasdaq Capital                                                                                            
 Market under the symbol “SXTP.”                                                                                                          
 There is no established public trading market                                                                                            
 for the Pre-Funded Warrants or the Warrants and we do not expect a market to develop. In addition, we do not intend to apply to list the 
 Pre-Funded Warrants or the Warrants on any national securities exchange or other nationally recognized trading system. Without an active 
 trading market, the liquidity of the Pre-Funded Warrants and the Warrants will be limited.                                               |

| Risk Factors                 |     | You should carefully consider the information set forth in this prospectus and, in particular, the specific factors set forth in the “Risk Factors” section beginning on page 19 of this prospectus and the risk factors in our most recent Annual Report on Form 10-K before deciding whether or not to invest in our securities.                                                                                      |
| Transfer Agent and registrar |     | Equity Stock Transfer, LLC                                                                                                                                                                                                                                                                                                                                                                                              |
| Reasonable best efforts      |     | The placement agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered by this prospectus. The placement agent is not purchasing or selling any of the securities we are offering and the placement agent is not required to arrange the purchase or sale of any specific number of securities or dollar amount. See “Plan of Distribution” on page 35 of this prospectus. |
| Dividend Policy              |     | We have never declared or paid any cash dividends on our shares of common stock. We do not anticipate paying any cash dividends in the foreseeable future.                                                                                                                                                                                                                                                              |

| (1) | The number of shares of common stock to be outstanding after this offering is based on 1,472,891 shares of Common Stock outstanding as of July 2, 2025 and excludes: |

| ● | 57,068 shares of common stock reserved for future issuance under the 2022 Plan; |

| ● | 2,127,070 shares of common